title: [Indications and follow-up of total pelvic exenteration].
abstract: From 1988 to 1996 we performed 18 total pelvic exenterations in patients with an average age of 59.8 years who could be followed up for a mean 29.8 months. In 10 cases a recurrent tumor of the pelvic viscera and 7 times a primary carcinoma of the rectum, bladder or prostate were treated. In 1 patient a radiogenic fistula led to this operation. Intestinal continuity could be reconstructed in 7 cases. Following cystectomy, urinary diversion was accomplished in half of the cases by an ileal conduit. Due to septic multiorgan failure 2 patients died postoperatively (hospital mortality rate 11%). In 82% a complete resection (R0) was possible. Subsequently 5 patients (29%) developed tumor recurrence. Distant metastases were observed in 3 patients, 8-9 months after surgery. So far 10 further patients have died. Their mean survival time was 28.9 months (range 5-99 months). The remaining 6 patients are still alive between 22 and 36 months postoperatively. Despite the extent of this kind of major surgery, which also requires multidisciplinary cooperation, and the psychosocial problems resulting from two permanent stomas, total pelvic exenteration should be regarded as an adequate alternative in the treatment plan in selected patients with locally advanced or recurrent pelvic disease.
authors.affiliation: Chirurgische Klinik, Krankenhaus Gerresheim, Kliniken der Landeshauptstadt Düsseldorf.
authors.forename: M
authors.initials: M
authors.lastname: Aleksic
authors.forename: N
authors.initials: N
authors.lastname: Hennes
authors.forename: B J
authors.initials: BJ
authors.lastname: Schmitz-Dräger
authors.forename: B
authors.initials: B
authors.lastname: Ulrich
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D009367:Neoplasm Staging; D010348:Patient Care Team; D010385:Pelvic Exenteration; D010386:Pelvic Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications / Q000401:mortality / Q000473:pathology / Q000601:surgery; D011788:Quality of Life; D012086:Reoperation; D015996:Survival Rate; D014547:Urinary Diversion
vernacular_title: Indikationsstellung und Verlauf bei der totalen pelvinen Exenteration.